Filter
2930
Filtered Results: 2930
Text search:
drug
market
Featured
Recommendations
260
New Publications
815
Language
Document type
No document type
1716
Studies & Reports
491
Guidelines
380
Manuals
132
Strategic & Response Plan
112
Fact sheets
38
Training Material
35
Situation Updates
10
Resource Platforms
7
Infographics
6
Brochures
1
App
1
Online Courses
1
Countries / Regions
India
197
Global
116
Kenya
99
Uganda
80
Ethiopia
80
Nigeria
66
South Africa
65
Western and Central Europe
61
Ghana
50
Sierra Leone
49
Liberia
48
Malawi
47
Bangladesh
47
Nepal
46
Myanmar / Burma
46
Tanzania
45
Zambia
42
Rwanda
37
Africa
36
Latin America and the Carribbean
36
South–East Asia Region
31
Philippines
30
Namibia
29
Zimbabwe
27
Ukraine
25
Eastern Europe
23
Lesotho
21
Cambodia
21
Congo, Democratic Republic of
21
Indonesia
19
Syria
18
Asia
18
Botswana
18
Russia
15
Senegal
12
Mozambique
12
Eswatini/ Swaziland
11
Burkina Faso
10
Venezuela
10
East and Southern Africa
10
Brazil
10
USA
9
Middle East and North Africa
9
Eastern Europe and Central Asia
9
Thailand
8
Cameroon
8
Albania
8
Guinea
8
West and Central Africa
8
Georgia
8
South Sudan
8
Germany
7
Laos
6
Haiti
6
Vietnam
6
Sudan
6
Tajikistan
5
Colombia
5
China
5
North America
5
Mexico
4
Western Pacific Region
4
Lebanon
4
Sri Lanka
4
Central African Republic
4
Libya
4
Iraq
4
North Macedonia
3
Timor Leste/ East Timor
3
Benin
3
Iran
3
Peru
3
Jordan
3
Paraguay
3
Papua New Guinea
3
Moldova
3
Bhutan
3
Somalia
3
Pakistan
3
Turkey
2
Chile
2
Fiji
2
Kyrgyzstan
2
Afghanistan
2
Morocco
2
Hungary
2
Tunisia
2
Argentina
2
Yemen
2
Palestine
2
Poland
2
Mali
2
North Korea
1
Serbia
1
Gambia
1
Kazakhstan
1
Canada
1
Estonia
1
Uzbekistan
1
Qatar
1
Bulgaria
1
Italy
1
Armenia
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Jamaica
1
Denmark
1
Maldives
1
Mauritius
1
Norway
1
Portugal
1
Bolivia
1
Greece
1
Angola
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1203
Clinical Guidelines
251
Public Health
159
Women & Child Health
89
Key Resources
87
Pharmacy & Technologies
47
Capacity Building
35
Toolboxes
HIV
300
Mental Health
291
TB
190
AMR
176
Pharmacy
143
COVID-19
119
NTDs
101
NCDs
71
Caregiver
50
Rapid Response
42
Planetary Health
40
Conflict
38
Ebola & Marburg
37
Refugee
35
Global Health Education
34
Health Financing Toolbox
30
Disability
29
Natural Hazards
13
Cholera
13
Specific Hazards
10
Malaria
8
Social Ethics
7
Polio
7
Zika
4
MICROBIAL DRUG RESISTANCEVolume 24, Number 5, 2018ªMary Ann Liebert, Inc.DOI: 10.1089/mdr.2017.0383
Antibiotic resistance (ABR) is a worldwide publichealth concern, with serious health, economic, and so-cietal repercussions. Its emergence is attributed to the se-lective pressure exerted by antib...
There is an expanding market of no- and low-alcohol beverages (NoLos). However, their effects on global ethanol consumption and public health are still questioned. Policies and regulations about NoLos’ availability, acceptability and affordability are lacking and evidence about their benefits is l...
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was...
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- and XDR-TB, health workers in
TB clinics (in district hospitals and some accredited health centres) wil...
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac...
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss of confidence in health prof...
This guideline provides advice in regards to applications for Marketing Authorisations for antimicrobial veterinary medicinal products (VMPs) on the data required and the methodology to be used for performing an assessment of the risk to public health from antimicrobial resistance (AMR) due to use o...
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those ...
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T...
BMC Infectious Diseases (2019) 19:832
Intestinal schistosomiasis is highly endemic in Tanzania and mass drug administration (MDA) using
praziquantel is the mainstay of the control program. However, the MDA program covers only school aged children
and does not include neither adult individuals nor...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
This document describes the key areas that national governments should consider for the introduction and scale-up of point-of-care (POC) diagnostics within national programmes, as new innovative POC technologies are being introduced into the market. The next steps taken to include these new innovati...
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato...
